GSA Capital Partners’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-425,303
| Closed | -$489K | – | 1928 |
|
|
2025
Q1 | $489K | Buy |
425,303
+331,821
| +355% | +$382K | 0.04% | 817 |
|
|
2024
Q4 | $571K | Buy |
93,482
+36,728
| +65% | +$224K | 0.04% | 785 |
|
|
2024
Q3 | $939K | Sell |
56,754
-5,227
| -8% | -$86.5K | 0.07% | 509 |
|
|
2024
Q2 | $426K | Buy |
61,981
+43,583
| +237% | +$300K | 0.03% | 1068 |
|
|
2024
Q1 | $178K | Buy |
+18,398
| New | +$178K | 0.01% | 1427 |
|
|
2023
Q4 | – | Sell |
-133,276
| Closed | -$1.11M | – | 1692 |
|
|
2023
Q3 | $1.11M | Buy |
133,276
+26,358
| +25% | +$220K | 0.1% | 339 |
|
|
2023
Q2 | $987K | Buy |
106,918
+59,733
| +127% | +$551K | 0.1% | 315 |
|
|
2023
Q1 | $648K | Buy |
47,185
+17,324
| +58% | +$238K | 0.06% | 551 |
|
|
2022
Q4 | $508K | Buy |
29,861
+11,682
| +64% | +$199K | 0.06% | 592 |
|
|
2022
Q3 | $413K | Sell |
18,179
-3,738
| -17% | -$84.9K | 0.05% | 720 |
|
|
2022
Q2 | $395K | Sell |
21,917
-14,600
| -40% | -$263K | 0.06% | 649 |
|
|
2022
Q1 | $976K | Buy |
36,517
+28,847
| +376% | +$771K | 0.13% | 189 |
|
|
2021
Q4 | $225K | Buy |
7,670
+2,265
| +42% | +$66.4K | 0.03% | 1135 |
|
|
2021
Q3 | $355K | Buy |
5,405
+509
| +10% | +$33.4K | 0.04% | 905 |
|
|
2021
Q2 | $407K | Buy |
4,896
+1,064
| +28% | +$88.4K | 0.05% | 769 |
|
|
2021
Q1 | $294K | Sell |
3,832
-2,719
| -42% | -$209K | 0.05% | 658 |
|
|
2020
Q4 | $578K | Buy |
+6,551
| New | +$578K | 0.09% | 342 |
|